Offres d'emploi
Trouvez des postes près de chez vous, sur site, hybrides ou à distance.- Emplois similaires à : Formulation & Regulatory Chemist
Associate Principal Scientist - Formulation (Complex Meds)
SRGCheadle
Exciting Opportunity: Associate Principal Scientist - Formulation - Complex Meds Are you a formulation expert with a passion for solving complex drug product development challenges? This innovative ph
Chemicals Regulatory Officer
SRGUnited KingdomChemical Regulatory Affairs Officer Hybrid working from Somerset site Salary - £40,000 - £50,000 (depending on experience) Permanent SRG is working with a leading manufacturer of sustainable specialit
Principal Formulation Development Scientist I - Oxford
ImmunocoreSutton WickPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreWaltham Saint LawrencePrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreHighclerePrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreNorth HinkseyPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreMapledurhamPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreChalfont Saint GilesPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreMortimer CommonPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreUnited KingdomPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreStow on the WoldPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreMoreton in MarshPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
Principal Formulation Development Scientist I - Oxford
ImmunocoreOxfordPrincipal Formulation Development Scientist I - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a
